Depo-Provera, commonly referred to as the birth control shot, is the brand name of the medication depot medroxyprogesterone acetate (DMPA). DMPA contains progestin, a synthetic hormone that works ...

The South African Health Products Regulatory Authority (SAHPRA) has recommended that the product information for ...

A March 2024 study published in the British Medical Journal cemented a positive correlation between medroxyprogesterone acetate (MPA), the synthetic hormone found in Depo-Provera, and the tumors.

The statute of limitations on Depo-Provera ® claims is a deadline that determines how long you have to take legal action for a brain tumor caused by the birth control shot. In some states, you may ...

Filing a lawsuit can feel overwhelming, especially when it involves a health concern like a brain tumor potentially linked to Depo-Provera. This contraceptive shot, widely used for years ...

MPA-containing products available in South Africa include Depo-Provera, Provera, Petogen, Medroxyprogesterone Mylan, Sayana, Omrastoz, Trivina, and Triclogyn. SAHPRA’s decision comes after the ...

Study reveals Depo-Provera exposure causes distinct genetic mutations in meningiomas, with increased risk of multiple tumors, particularly at the skull base The DNA footprint of meningiomas in ...

MPA-containing products registered in South Africa are Depo-Provera, Provera, Petogen, Medroxyprogesterone Mylan, Sayana, Omrastoz, Trivina, and Triclogyn. Sahpra said it was informed by a holder ...

There have been 32 cases of meningioma reported in 20 years globally, however none have been reported in South Africa.